Outcome Domains for Studies of Acute and Chronic Gout
Top Cited Papers
Open Access
- 8 October 2009
- journal article
- Published by The Journal of Rheumatology in The Journal of Rheumatology
- Vol. 36 (10) , 2342-2345
- https://doi.org/10.3899/jrheum.090370
Abstract
Discussion and voting at OMERACT 9 confirmed 5 essential domains for outcomes of acute gout: pain, joint swelling, joint tenderness, patient global assessment and activity limitations. For studies in chronic gout 7 essential domains are: serum urate, acute gout attacks, tophus burden, health-related quality of life, activity limitations, pain, and patient global assessment. Implications of patient perspectives, discretionary domains for specific studies, measurement instruments and a possible responder index are under study.Keywords
This publication has 8 references indexed in Scilit:
- Progress in Measurement Instruments for Acute and Chronic Gout StudiesThe Journal of Rheumatology, 2009
- A modified Delphi exercise to determine the extent of consensus with OMERACT outcome domains for studies of acute and chronic goutAnnals of the Rheumatic Diseases, 2008
- SLC2A9 is a newly identified urate transporter influencing serum urate concentration, urate excretion and goutNature Genetics, 2008
- Associations between gout tophus and polymorphisms 869T/C and -509C/T in transforming growth factor 1 geneRheumatology, 2008
- PEG-uricase in the management of treatment-resistant gout and hyperuricemiaAdvanced Drug Delivery Reviews, 2007
- Gout-associated uric acid crystals activate the NALP3 inflammasomeNature, 2006
- Febuxostat Compared with Allopurinol in Patients with Hyperuricemia and GoutNew England Journal of Medicine, 2005
- Development of ICF Core Sets for patients with chronic conditionsJournal of Rehabilitation Medicine, 2004